216 related articles for article (PubMed ID: 14971604)
1. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Hashimoto T; Koizumi K; Nishina T; Abe K
Ann Nucl Med; 2003 Dec; 17(8):633-40. PubMed ID: 14971604
[TBL] [Abstract][Full Text] [Related]
2. [123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma].
Okuyama C; Ushijima Y; Sugihara H; Okitsu S; Maeda T
Kaku Igaku; 1998 Nov; 35(9):835-42. PubMed ID: 9916399
[TBL] [Abstract][Full Text] [Related]
3. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
4. [Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics].
Okuyama C; Ushijima Y; Watanabe K; Sugihara H; Nishimura T
Kaku Igaku; 1999 Oct; 36(8):827-34. PubMed ID: 10586543
[TBL] [Abstract][Full Text] [Related]
5. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Fukuoka M; Taki J; Mochizuki T; Kinuya S
Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
[TBL] [Abstract][Full Text] [Related]
7. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
[TBL] [Abstract][Full Text] [Related]
10. Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
Černý I; Prášek J; Kašpárková H
Nuklearmedizin; 2016 Aug; 55(4):151-7. PubMed ID: 27054367
[TBL] [Abstract][Full Text] [Related]
11. Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Okuyama C; Ushijima Y; Kubota T; Nakamura T; Kikkawa M; Nishimura T
Nucl Med Commun; 2002 Jul; 23(7):663-72. PubMed ID: 12089489
[TBL] [Abstract][Full Text] [Related]
12. [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
Rufini V; Giordano A; Di Giuda D; Petrone A; Deb G; De Sio L; Donfrancesco A; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):25-8. PubMed ID: 9002745
[TBL] [Abstract][Full Text] [Related]
13. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
[TBL] [Abstract][Full Text] [Related]
14. Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.
van der Palen RL; Bulten BF; Mavinkurve-Groothuis AM; Bellersen L; van Laarhoven HW; Kapusta L; de Geus-Oei LF
Nuklearmedizin; 2013 Dec; 52(6):228-34. PubMed ID: 24045423
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
16. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
17. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.
Rufini V; Fisher GA; Shulkin BL; Sisson JC; Shapiro B
J Nucl Med; 1996 Sep; 37(9):1464-8. PubMed ID: 8790194
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site.
Gauthé M; Breton M; Jehanno N; Cellier C; Michon J; Sarnacki S; Schleiermacher G; Wartski M
Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):131-138. PubMed ID: 29409315
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
20. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
Hibi S; Todo S; Imashuku S; Miyazaki T
Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
